Clinical and molecular characterization of a large cohort of childhood onset hereditary spastic paraplegias

Abstract The present study aimed to characterize clinical and molecular data of a large cohort of subjects with childhood-onset hereditary spastic paraplegias (HSPs). A multicenter historical cohort was performed at five centers in Brazil, in which probands and affected relatives' data from con...

Full description

Bibliographic Details
Main Authors: Gabriela Marchisio Giordani, Fabrício Diniz, Helena Fussiger, Carelis Gonzalez-Salazar, Karina Carvalho Donis, Fernando Freua, Roberta Paiva Magalhães Ortega, Julian Letícia de Freitas, Orlando Graziani Povoas Barsottini, Sergio Rosemberg, Fernando Kok, José Luiz Pedroso, Marcondes Cavalcante França, Jonas Alex Morales Saute
Format: Article
Language:English
Published: Nature Portfolio 2021-11-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-021-01635-2
_version_ 1818928922476150784
author Gabriela Marchisio Giordani
Fabrício Diniz
Helena Fussiger
Carelis Gonzalez-Salazar
Karina Carvalho Donis
Fernando Freua
Roberta Paiva Magalhães Ortega
Julian Letícia de Freitas
Orlando Graziani Povoas Barsottini
Sergio Rosemberg
Fernando Kok
José Luiz Pedroso
Marcondes Cavalcante França
Jonas Alex Morales Saute
author_facet Gabriela Marchisio Giordani
Fabrício Diniz
Helena Fussiger
Carelis Gonzalez-Salazar
Karina Carvalho Donis
Fernando Freua
Roberta Paiva Magalhães Ortega
Julian Letícia de Freitas
Orlando Graziani Povoas Barsottini
Sergio Rosemberg
Fernando Kok
José Luiz Pedroso
Marcondes Cavalcante França
Jonas Alex Morales Saute
author_sort Gabriela Marchisio Giordani
collection DOAJ
description Abstract The present study aimed to characterize clinical and molecular data of a large cohort of subjects with childhood-onset hereditary spastic paraplegias (HSPs). A multicenter historical cohort was performed at five centers in Brazil, in which probands and affected relatives' data from consecutive families with childhood-onset HSP (onset < 12 years-old) were reviewed from 2011 to 2020. One hundred and six individuals (83 families) with suspicion of childhood-onset HSP were evaluated, being 68 (50 families) with solved genetic diagnosis, 6 (5 families) with candidate variants in HSP-related genes and 32 (28 families) with unsolved genetic diagnosis. The most common childhood-onset subtype was SPG4, 11/50 (22%) families with solved genetic diagnosis; followed by SPG3A, 8/50 (16%). Missense pathogenic variants in SPAST were found in 54.5% of probands, favoring the association of this type of variant to childhood-onset SPG4. Survival curves to major handicap and cross-sectional Spastic Paraplegia Rating Scale progressions confirmed the slow neurological deterioration in SPG4 and SPG3A. Most common complicating features and twenty variants not previously described in HSP-related genes were reported. These results are fundamental to understand the molecular and clinical epidemiology of childhood-onset HSP, which might help on differential diagnosis, patient care and guiding future collaborative trials for these rare diseases.
first_indexed 2024-12-20T03:36:36Z
format Article
id doaj.art-073d2145390142cba71bb2a8e6f713c7
institution Directory Open Access Journal
issn 2045-2322
language English
last_indexed 2024-12-20T03:36:36Z
publishDate 2021-11-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj.art-073d2145390142cba71bb2a8e6f713c72022-12-21T19:54:51ZengNature PortfolioScientific Reports2045-23222021-11-011111910.1038/s41598-021-01635-2Clinical and molecular characterization of a large cohort of childhood onset hereditary spastic paraplegiasGabriela Marchisio Giordani0Fabrício Diniz1Helena Fussiger2Carelis Gonzalez-Salazar3Karina Carvalho Donis4Fernando Freua5Roberta Paiva Magalhães Ortega6Julian Letícia de Freitas7Orlando Graziani Povoas Barsottini8Sergio Rosemberg9Fernando Kok10José Luiz Pedroso11Marcondes Cavalcante França12Jonas Alex Morales Saute13Graduate Program in Medicine: Medical Sciences, Universidade Federal do Rio Grande do SulGraduate Program in Medical Physiopathology, Universidade Estadual de Campinas (UNICAMP)Graduate Program in Medicine: Medical Sciences, Universidade Federal do Rio Grande do SulGraduate Program in Medical Physiopathology, Universidade Estadual de Campinas (UNICAMP)Neurogenetics, Clinical Research Center, Hospital de Clínicas de Porto Alegre (HCPA)Departamento de Neurologia, Hospital das Clínicas, Universidade de São PauloIrmandade da Santa Casa de Misericórdia de São PauloDepartment of Neurology, Ataxia Unit Universidade Federal de São PauloDepartment of Neurology, Ataxia Unit Universidade Federal de São PauloIrmandade da Santa Casa de Misericórdia de São PauloDepartamento de Neurologia, Hospital das Clínicas, Universidade de São PauloDepartment of Neurology, Ataxia Unit Universidade Federal de São PauloGraduate Program in Medical Physiopathology, Universidade Estadual de Campinas (UNICAMP)Graduate Program in Medicine: Medical Sciences, Universidade Federal do Rio Grande do SulAbstract The present study aimed to characterize clinical and molecular data of a large cohort of subjects with childhood-onset hereditary spastic paraplegias (HSPs). A multicenter historical cohort was performed at five centers in Brazil, in which probands and affected relatives' data from consecutive families with childhood-onset HSP (onset < 12 years-old) were reviewed from 2011 to 2020. One hundred and six individuals (83 families) with suspicion of childhood-onset HSP were evaluated, being 68 (50 families) with solved genetic diagnosis, 6 (5 families) with candidate variants in HSP-related genes and 32 (28 families) with unsolved genetic diagnosis. The most common childhood-onset subtype was SPG4, 11/50 (22%) families with solved genetic diagnosis; followed by SPG3A, 8/50 (16%). Missense pathogenic variants in SPAST were found in 54.5% of probands, favoring the association of this type of variant to childhood-onset SPG4. Survival curves to major handicap and cross-sectional Spastic Paraplegia Rating Scale progressions confirmed the slow neurological deterioration in SPG4 and SPG3A. Most common complicating features and twenty variants not previously described in HSP-related genes were reported. These results are fundamental to understand the molecular and clinical epidemiology of childhood-onset HSP, which might help on differential diagnosis, patient care and guiding future collaborative trials for these rare diseases.https://doi.org/10.1038/s41598-021-01635-2
spellingShingle Gabriela Marchisio Giordani
Fabrício Diniz
Helena Fussiger
Carelis Gonzalez-Salazar
Karina Carvalho Donis
Fernando Freua
Roberta Paiva Magalhães Ortega
Julian Letícia de Freitas
Orlando Graziani Povoas Barsottini
Sergio Rosemberg
Fernando Kok
José Luiz Pedroso
Marcondes Cavalcante França
Jonas Alex Morales Saute
Clinical and molecular characterization of a large cohort of childhood onset hereditary spastic paraplegias
Scientific Reports
title Clinical and molecular characterization of a large cohort of childhood onset hereditary spastic paraplegias
title_full Clinical and molecular characterization of a large cohort of childhood onset hereditary spastic paraplegias
title_fullStr Clinical and molecular characterization of a large cohort of childhood onset hereditary spastic paraplegias
title_full_unstemmed Clinical and molecular characterization of a large cohort of childhood onset hereditary spastic paraplegias
title_short Clinical and molecular characterization of a large cohort of childhood onset hereditary spastic paraplegias
title_sort clinical and molecular characterization of a large cohort of childhood onset hereditary spastic paraplegias
url https://doi.org/10.1038/s41598-021-01635-2
work_keys_str_mv AT gabrielamarchisiogiordani clinicalandmolecularcharacterizationofalargecohortofchildhoodonsethereditaryspasticparaplegias
AT fabriciodiniz clinicalandmolecularcharacterizationofalargecohortofchildhoodonsethereditaryspasticparaplegias
AT helenafussiger clinicalandmolecularcharacterizationofalargecohortofchildhoodonsethereditaryspasticparaplegias
AT carelisgonzalezsalazar clinicalandmolecularcharacterizationofalargecohortofchildhoodonsethereditaryspasticparaplegias
AT karinacarvalhodonis clinicalandmolecularcharacterizationofalargecohortofchildhoodonsethereditaryspasticparaplegias
AT fernandofreua clinicalandmolecularcharacterizationofalargecohortofchildhoodonsethereditaryspasticparaplegias
AT robertapaivamagalhaesortega clinicalandmolecularcharacterizationofalargecohortofchildhoodonsethereditaryspasticparaplegias
AT julianleticiadefreitas clinicalandmolecularcharacterizationofalargecohortofchildhoodonsethereditaryspasticparaplegias
AT orlandograzianipovoasbarsottini clinicalandmolecularcharacterizationofalargecohortofchildhoodonsethereditaryspasticparaplegias
AT sergiorosemberg clinicalandmolecularcharacterizationofalargecohortofchildhoodonsethereditaryspasticparaplegias
AT fernandokok clinicalandmolecularcharacterizationofalargecohortofchildhoodonsethereditaryspasticparaplegias
AT joseluizpedroso clinicalandmolecularcharacterizationofalargecohortofchildhoodonsethereditaryspasticparaplegias
AT marcondescavalcantefranca clinicalandmolecularcharacterizationofalargecohortofchildhoodonsethereditaryspasticparaplegias
AT jonasalexmoralessaute clinicalandmolecularcharacterizationofalargecohortofchildhoodonsethereditaryspasticparaplegias